Alpha-synuclein has been implicated in Parkinson disease, yet the mechanism by which alpha-synuclein causes cell injury is not understood. Using a transgenic mouse model, we evaluated the effect of alphasynuclein overexpression on gene expression in the substantia nigra. Nigral mRNA from wild type and alpha-synuclein transgenic mice was analyzed using Affymetrix gene arrays. At 3 months, before pathological changes are apparent, we observed modest alterations in gene expression. However, nearly 200 genes were altered in expression at 9 months, when degenerative changes are more apparent. Functional genomic analysis revealed that the genes altered at 9 months were predominantly involved in gene transcription. As in human Parkinson disease, gene expression changes in the transgenic model were also modulated by gender. These data demonstrate that alterations of gene expression are widespread in this animal model, and suggest that transcriptional dysregulation may be a disease mechanism that can be targeted therapeutically.
Introduction
Parkinson disease (PD) is a debilitating neurological disorder associated with dopaminergic cell loss in the substantia nigra (SN). Familial PD cases have been linked to several genes, including α-synuclein (α-syn), a 140-amino-acid protein that may function in neurotransmitter release (Abeliovich et al., 2000; Murphy et al., 2000) . Families with mutated α-syn exhibit autosomal dominant PD (Athanassiadou et al., 1999; Kruger et al., 1998; Polymeropoulos et al., 1997; Zarranz et al., 2004) , and gene multiplication leading to increased wild type α-syn levels also causes disease (Singleton et al., 2003) . Certain α-syn promoter polymorphisms are PD risk factors, suggesting that even modest increases in expression can predispose to disease (Farrer et al., 2001; Kruger et al., 1999; Pals et al., 2004; Tan et al., 2000; Wang et al., 2006) . In patients without genetic mutations, α-syn is found in Lewy bodies and degenerating neurites (Irizarry et al., 1998; Spillantini et al., 1997) .
Alpha-syn overexpression has been used to generate cellular and animal models of PD. Mutant α-syn or overexpression of wild type α-syn induces cell death in dopaminergic cell lines and in primary dopaminergic cultures (Oluwatosin-Chigbu et al., 2003; Xu et al., 2002; Zhou et al., 2000 Zhou et al., , 2002 . Transgenic mice expressing mutant or wild type α-syn show motor deficits, alterations in dopamine levels, and α-syn-positive inclusions (Hashimoto et al., 2003; Maries et al., 2003) . Alpha-syn is also involved in the action of neurotoxins, such as MPTP and rotenone, used to model PD (Dauer et al., 2002; Betarbet et al., 2000) .
The mechanism by which α-syn injures dopaminergic neurons remains unclear. A potential mechanism not closely examined is transcriptional dysregulation, in which interference with normal gene expression patterns leads to cellular dysfunction. Transcriptional dysregulation has been implicated in Huntington's and Alzheimer's diseases (Cha, 2000; Robakis, 2003) . Using microarray methods, we have observed that PD causes gene expression alterations in human dopaminergic neurons (Cantuti-Castelvetri et al., 2007) . Alpha-syn can also inhibit histone acetylation, a potent mechanism for altering gene expression (Kontopoulos et al., 2006) .
